PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
9408183-9	1997	exhibited antagonism against RII in CAR.	rii	29-32	nuclear receptor subfamily 1, group I, member 3	Rattus norvegicus	36-39
15059906-7	2004	Histone H1 kinase assays indicated that the delayed entry of RII transfectants into phase was associated with markedly reduced cyclin-dependent kinase (CDK)2 kinase activity.	rii	61-64	cyclin dependent kinase 2	Homo sapiens	152-157
15059906-9	2004	Tetracycline treatment of RII transfectants led to the suppression of p21/waf1/cip1and p27/kip expression, thus, directly demonstrating induction of CDK inhibitors by autocrine TGF-beta leading to growth control of ER(+) breast cancer cells.	rii	26-29	cyclin dependent kinase inhibitor 1A	Homo sapiens	70-83
15059906-9	2004	Tetracycline treatment of RII transfectants led to the suppression of p21/waf1/cip1and p27/kip expression, thus, directly demonstrating induction of CDK inhibitors by autocrine TGF-beta leading to growth control of ER(+) breast cancer cells.	rii	26-29	dynactin subunit 6	Homo sapiens	87-90
15059906-9	2004	Tetracycline treatment of RII transfectants led to the suppression of p21/waf1/cip1and p27/kip expression, thus, directly demonstrating induction of CDK inhibitors by autocrine TGF-beta leading to growth control of ER(+) breast cancer cells.	rii	26-29	transforming growth factor beta 1	Homo sapiens	177-185